GI

Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

Thursday, October 28, 2021 - 4:23am

Incorporates Seegene's broad menu of molecular diagnostics for syndromic testing, for detection of SARS-CoV-2 and variants.

Key Points: 
  • Incorporates Seegene's broad menu of molecular diagnostics for syndromic testing, for detection of SARS-CoV-2 and variants.
  • "Seegene has played a critical role in the global response to the COVID-19 pandemic, in large part because of our forward-looking strategy.
  • "As we look ahead, the most pressing diagnostic need will be for cost-effective and high throughput automated systems that can remove any remaining testing bottlenecks.
  • The modular design ofSTARlet-AIOS: All-in-One Systemunites twostandalone instrumentsthe STARlet IVD and the CFX96 Dx real-time PCR Systemwitha custom-built robotic arm.

Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

Wednesday, October 27, 2021 - 4:22pm

Utilizes Seegene's broad menu of molecular diagnostics for syndromic testing, for detection of SARS-CoV-2 and variants.

Key Points: 
  • Utilizes Seegene's broad menu of molecular diagnostics for syndromic testing, for detection of SARS-CoV-2 and variants.
  • "Seegene has played a critical role in the global response to the COVID-19 pandemic, in large part because of our forward-looking strategy.
  • "As we look ahead, the most pressing diagnostic need will be for cost-effective and high throughput automated systems that can remove any remaining testing bottlenecks.
  • The modular design ofSTARlet-AIOS: All-in-One Systemunites twostandalone instrumentsthe STARlet IVD and the CFX96 Dx real-time PCR Systemwitha custom-built robotic arm.

Inhibikase Therapeutics to Participate in Upcoming Michael J. Fox Foundation Alpha-Synuclein Summit

Wednesday, October 27, 2021 - 1:05pm

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders.

Key Points: 
  • Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders.
  • Inhibikase has completed its Phase 1 studies evaluating the safety, tolerability and pharmacokinetics of IkT-148009 in older and healthy subjects and has commenced a Phase 1b study in Parkinson's patients.
  • Inhibikase is headquartered in Atlanta, Georgia with offices in Boston, Massachusetts.
  • This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

Americans Lack General Understanding Around Signs Of Serious GI Conditions, Including Exocrine Pancreatic Insufficiency

Wednesday, October 27, 2021 - 1:00pm

Even more concerning, severe GI conditions, such as EPI, can be difficult to recognize and are often under or misdiagnosed delaying critical treatment that can greatly improve quality of life.

Key Points: 
  • Even more concerning, severe GI conditions, such as EPI, can be difficult to recognize and are often under or misdiagnosed delaying critical treatment that can greatly improve quality of life.
  • "This data brings to light that we have a tremendous opportunity to improve the quality of life for many Americans.
  • Now is the time to talk to a GI specialist you don't have to suffer in silence."
  • Half of people (49%) have experienced GI symptoms that impacted their daily life and activities within the last year.

OneLavi.com Now offers Health and Wisdom’s Topical Magnesium Product Line

Tuesday, October 26, 2021 - 8:36pm

PALM BEACH, FL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- OneLavi.com , a popular boutique health, beauty, and wellness website, now carries Health and Wisdoms topical magnesium products.

Key Points: 
  • PALM BEACH, FL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- OneLavi.com , a popular boutique health, beauty, and wellness website, now carries Health and Wisdoms topical magnesium products.
  • We are excited that One Lavi , a high-quality health and wellness website, offers our premium topical magnesium products to its customers, said Laura Collinwood, President of Health and Wisdom, which sources its raw magnesium chloride oil in the United States.
  • Based in Missouri, Health and Wisdoms topical magnesium products, which contain all-natural minerals and ingredients, include:
    Magnesium Oil USP with Aloe Vera: Purified, full-strength magnesium chloride with organic aloe vera, one of natures finest moisturizers.
  • Magnesium Gel: Less concentrated, Magnesium Gel provides the benefits of purified magnesium chloride formulated with seaweed extract for people with sensitive skin.

Processa Pharmaceuticals Schedules Conference Call to Discuss Third Quarter Results and Provide Drug Development Update on November 11 at 5:30 p.m. EST

Tuesday, October 26, 2021 - 1:30pm

The Company will host a conference call at 5:30 p.m. Eastern Time on Thursday November 11, 2021 to discuss its financial results and business highlights.

Key Points: 
  • The Company will host a conference call at 5:30 p.m. Eastern Time on Thursday November 11, 2021 to discuss its financial results and business highlights.
  • To participate in this event, please log-on or dial-in approximately 5-10 minutes before the beginning of the call.
  • The Company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently.
  • Active clinical pipeline programs include: PCS6422 (metastatic colorectal cancer and breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (GI motility/gastroparesis).

Motus GI Announces Presentation of Results from Independent Study of Pure-Vu System in IBP Patients at the 2021 ACG Annual Scientific Meeting

Tuesday, October 26, 2021 - 1:00pm

We are excited to see the positive results of this real-world, independent study of the Pure-Vu System supporting both inpatient and outpatient procedures for screening and emergency colonoscopies at the ACG meeting.

Key Points: 
  • We are excited to see the positive results of this real-world, independent study of the Pure-Vu System supporting both inpatient and outpatient procedures for screening and emergency colonoscopies at the ACG meeting.
  • Of the 40 procedures that we completed, the Pure-Vu was used as an adjunct to IBP to allow completion of procedure in 37 patients.
  • Additionally, we successfully completed three procedures without any bowel preparation in patients with lower GI bleeds.
  • In patients with IBP, the mean BBPS score improved from 3.1 (range: 0-6) to 8.5 (range 5-9) after intra-procedural cleansing.

PanTheryx Unveils New Bovine Colostrum Product, ColostrumOne™ Extra Strength, at SupplySide West 2021

Tuesday, October 26, 2021 - 1:00pm

The study demonstrated ColostrumOne Extra Strengths ability to protect against intestinal damage and inflammation.

Key Points: 
  • The study demonstrated ColostrumOne Extra Strengths ability to protect against intestinal damage and inflammation.
  • We developed our new ColostrumOne Extra Strength with a unique matrix technology to protect the bioactive components of colostrum and to enhance bioavailability.
  • Attendees at this years SupplySide West event can visit the PanTheryx APS La Belle booth #3226 to learn more about ColostrumOne Extra Strength and the companys line of colostrum product offerings.
  • As the worlds largest producer of colostrum, PanTheryx provides its proprietary ColostrumOne and La Belle Colostrum ingredients to its partners serving the global human and animal health markets.

Unique Network Raises $11.3 Million For Next-Generation NFT Infrastructure

Monday, October 25, 2021 - 2:00pm

- Chris Cable, FlamingoDAO

Key Points: 
  • - Chris Cable, FlamingoDAO
    Despite all the current buzz around NFTs, there is still a massive barrier to entry, said Unique Network co-founder and CEO Alexander Mitrovich .
  • Unique Network will participate in the upcoming parachain auctions for Kusama, during which they aim to secure a parachain slot for Quartz, their new canary network for Kusama.
  • Quartz will be the first NFT infrastructure on Kusama, and is designed to enable the most powerful and advanced NFT functionality on the Kusama network.
  • With the impending launch of Quartz, Unique Network will be able to help even more projects and artists develop their NFT marketplaces and experiences.

Ironwood Pharmaceuticals to Host Third Quarter 2021 Investor Update Call

Thursday, October 21, 2021 - 12:00pm

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2021 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, November 4, 2021.

Key Points: 
  • Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its third quarter 2021 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, November 4, 2021.
  • The call will be available for replay via telephone starting Thursday, November 4, 2021 at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on November 18, 2021.
  • To listen to the replay, dial (800) 770-2030 (U.S. and Canada) or (647) 362-9199 (international) using conference ID number 4671230.
  • Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.